ERNAW
Financials
- Market Capitalization 7.4601 M
- Employee 5
- Founded 2018
- CEO N/A
- Website www.ernexatx.com
- Headquarter Delaware, United States
- FIGI BBG000CX5677
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5300 |  GRFS Grifols, S.A. - American Depositary Shares | 7.69 USD | -1.66% | -3.88% | -7.57% | -21.21% | 0 USD | ||
| 7287 |  SCLXW Scilex Holding Company - Warrant | 0.1579 USD | 0.00% | +20.53% | -16.89% | -65.67% | 46.12 M USD | ||
| 7357 |  MDCXW Medicus Pharma Ltd. - Warrant | 0.3302 USD | 0.00% | 0.00% | -33.95% | -57.65% | 16.43 M USD | ||
| 7387 |  LIMNW Liminatus Pharma, Inc. - Warrants | 0.0435 USD | -35.65% | -3.33% | -45.15% | -79.62% | 5.68 M USD |
Frequently asked questions about Ernexa Therapeutics Inc. Common Stock
What is the Ernexa Therapeutics Inc. Common Stock stock price today?
The current price of Ernexa Therapeutics Inc. Common Stock (ERNAW) is 0.0590. Over the past 24 hours, the stock has changed by -24.36%. Follow the ERNAW chart for real-time price dynamics.
What is the stock ticker of Ernexa Therapeutics Inc. Common Stock?
Ernexa Therapeutics Inc. Common Stock trades under the ticker ERNAW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ernexa Therapeutics Inc. Common Stock stock going up?
ERNAW has changed by +7.66% over the last week, +2.61% over the last month, and -41.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Ernexa Therapeutics Inc. Common Stock?
Ernexa Therapeutics Inc. Common Stock currently has a market capitalization of 7.46 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Ernexa Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Ernexa Therapeutics Inc. Common Stock reported earnings of -3.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Ernexa Therapeutics Inc. Common Stock revenue for the last quarter?
Ernexa Therapeutics Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Ernexa Therapeutics Inc. Common Stock net income for the last quarter?
Ernexa Therapeutics Inc. Common Stock reported net income of -4.01 M for the last quarter. The previous quarter showed -5.51 M, which means net income changed by +27.19%.
How many employees does Ernexa Therapeutics Inc. Common Stock have?
As of the latest available data, Ernexa Therapeutics Inc. Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Ernexa Therapeutics Inc. Common Stock stock?
You can buy Ernexa Therapeutics Inc. Common Stock (ERNAW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ernexa Therapeutics Inc. Common Stock stock?
Investing in Ernexa Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ERNAW chart and related analysis on metatrader.com as part of your research.